scholarly journals Hepatoma and medicine medical care. The hepatoma. The setting of a high risk group. Hepatitis B virus infectious disease and hepatoma.

1995 ◽  
Vol 84 (12) ◽  
pp. 1980-1984
Author(s):  
KAZUHIKO KOIKE
1994 ◽  
Vol 164 (4) ◽  
pp. 542-543 ◽  
Author(s):  
S. Chaudhury ◽  
S. Chandra ◽  
M. Augustine

In a study of 100 institutionalised patients with psychosis and an equal number of age- and sex-matched healthy controls from the same regional background, the prevalence of Australia antigen (HBsAg) was 11 and 2, respectively. Institutionalised psychotic patients are a high-risk group for hepatitis B virus infection.


BMJ ◽  
1987 ◽  
Vol 295 (6593) ◽  
pp. 309-310 ◽  
Author(s):  
H M Smith ◽  
G J Alexander ◽  
W Birnbaum ◽  
R Williams

2020 ◽  
Vol 20 (3) ◽  
pp. 35-41
Author(s):  
Thanom Namwong ◽  
Choosak Nithikathkul ◽  
Vorapoj Promsatayaprot ◽  
Sumattana Glangkarn

This study investigated the prevalence of Hepatitis B virus (HBV) and identified a predictive statistical model for the HBV exposure among people in the community, Yasothon, Thailand. A cross-sectional study was performed on participants over 26 years old and living in Muang district, Yasothon province, Thailand. The research was conducted from July to August 2019. All 1,258 participants were verbally screened. Four hundred and fifty nine people were the risk group and tested for HBsAg, and 18 cases were positive for HBsAg (3.9% [95%CI 3.5-4.4]). For the predictive model, the HBV exposure connected with sex, marital status, alcohol, smoking, and knowledge. The area under the receiver operating characteristics (ROC) curve was 61.8 % (95%CI, 58.6 to 65.0). At cut-off-point -0.66, the sensitivity, specificity and accuracy were 72.6%, 42.4 % and 53.4%, respectively. HBV infection was a serious health problem, it can cause cirrhosis and liver cancer in the future. The predictive model of five variables can predict risk exposure of HBV which may had other relevant factors. Verbal screening by questionnaire to classify HBsAg risk group can lower the implement cost.


Hepatology ◽  
1995 ◽  
Vol 22 (1) ◽  
pp. 44-49
Author(s):  
David Siegel ◽  
Miriam J. Alter ◽  
Stephen Morse

Vaccine ◽  
1999 ◽  
Vol 18 (7-8) ◽  
pp. 581-587 ◽  
Author(s):  
Hiroyuki Kato ◽  
Keisuke Nakata ◽  
Keisuke Hamasaki ◽  
Daisaku Hida ◽  
Hiroki Ishikawa ◽  
...  

1994 ◽  
Vol 4 (2) ◽  
pp. 99-102
Author(s):  
Masakazu Washjo ◽  
Noritaka Tokui ◽  
Seiya Okuda ◽  
Akinori Nagashima ◽  
Toru Sanai ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document